Enhancing Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Hold
3,800
0.24% 71
2026
Q1
$390K Hold
3,800
0.29% 65
2025
Q4
$476K Hold
3,800
0.34% 61
2025
Q3
$509K Hold
3,800
0.37% 62
2025
Q2
$517K Hold
3,800
0.39% 65
2025
Q1
$504K Hold
3,800
0.4% 66
2024
Q4
$430K Buy
+3,800
New +$439K 0.34% 70
2022
Q3
$387K Hold
3,800
0.48% 57
2022
Q2
$413K Hold
3,800
0.49% 54
2022
Q1
$450K Hold
3,800
0.48% 54
2021
Q4
$535K Buy
+3,800
New +$486K 0.58% 51

Other funds holding ABT

Enhancing Capital's ABT Position: Q2 2026 in Review

Enhancing Capital held its Abbott (ABT) position steady in Q2 2026 at 3,800 shares worth $345K. The position accounts for 0.24% of the portfolio, ranked #71.

Enhancing Capital first reported a position in ABT in Q4 2021 and has held it in 11 quarters since. The position peaked at $535K in Q4 2021. 2,972 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Enhancing Capital held 3,800 shares of Abbott worth $345K as of Q2 2026.
  • Enhancing Capital left its Abbott share count unchanged in Q2 2026.
  • Abbott made up 0.24% of Enhancing Capital's portfolio in Q2 2026, its #71 holding.
  • Enhancing Capital first reported a position in Abbott in Q4 2021 and has held it in 11 quarters since.
  • Enhancing Capital's Abbott position peaked at $535K in Q4 2021.
  • 2,972 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Enhancing Capital's 13F filing for Q2 2026, filed 11 Aug 2026.